Vabomere

Active Ingredient(s): Meropenem + Vaborbactam
FDA Approved: * August 29, 2017
Pharm Company: * REMPEX PHARMS MEDCNS
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vabomere Overview

Vaborbactam (INN)[1] is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the beta-lactamase enzymes that would otherwise degrade them. When combined with an appropriate antibiotic it can be used for the treatment of gram-negative bacterial infections.[2] According to a Medicines Company press release, as of June 20...

Read more Vabomere Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vaborbactam

Recent Vabomere Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Meropenem + Vaborbactam
  • Powder: 1gm/vial + 1gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vabomere: (1 result)

Sorted by National Drug Code
  • 65293-009 Vabomere Intravenous Injection, Powder, for Solution by The Medicines Company

Drugs with one or more similar ingredients: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 20 November 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.